AKNAD1 antibody

Principal name

AKNAD1 antibody

Alternative names for AKNAD1 antibody

C1orf62

SwissProt ID

Q5T1N1 (Human)

Gene ID

254268 (AKNAD1)

Available reactivities

Hu (Human)

Available hosts

Mouse

Available applications

Western blot / Immunoblot (WB)

Background of AKNAD1 antibody

Kit Component:
- KN215937G1, AKNAD1 gRNA vector 1 in pCas-Guide vector
- KN215937G2, AKNAD1 gRNA vector 2 in pCas-Guide vector
- KN215937D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

7 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

AKNAD1 antibody

AKNAD1 Mouse Hu WB
0.5 mg / €1,400.00
  Abnova Taiwan Corp.

CRISPR

Catalog No. Species Donor Vector  

AKNAD1 - human gene knockout kit via CRISPR

AKNAD1 - human gene knockout kit via CRISPR Human GFP-Puro
1 kit / €1,200.00
  OriGene Technologies, Inc.

AKNAD1 - human gene knockout kit via CRISPR

AKNAD1 - human gene knockout kit via CRISPR Human mBFP-Neo
1 kit / €1,290.00
  OriGene Technologies, Inc.

AKNAD1 - human gene knockout kit via CRISPR

AKNAD1 - human gene knockout kit via CRISPR Human Luciferase-Puro
1 kit / €1,290.00
  OriGene Technologies, Inc.

Lysates

Catalog No.    

AKNAD1 overexpression lysate

AKNAD1 overexpression lysate  
0.1 mg / €480.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, AKNAD1 (mGFP-tagged)-Human AKNA domain containing 1 (AKNAD1), 200 uL, >10^7 TU/mL

Lenti ORF particles, AKNAD1 (mGFP-tagged)-Human AKNA domain containing 1 (AKNAD1), 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, AKNAD1 (Myc-DDK-tagged)-Human AKNA domain containing 1 (AKNAD1), 200 uL, >10^7 TU/mL

Lenti ORF particles, AKNAD1 (Myc-DDK-tagged)-Human AKNA domain containing 1 (AKNAD1), 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

7 Item(s)

per page
  • LinkedIn